Recent statements from the Federal Drug Administration Commissioner suggest that the agency may be considering the legitimacy of medical marijuana claims, years after legalization of the herb for medicinal purposes has taken hold in over half of the country. Most specifically, the concern revolves around claims that cannabis has anti-tumor effects that can cause cancerous tumors to shrink.
“I see people who are developing products who are making claims that marijuana has antitumor effects in the setting of cancer,” FDA Commissioner Scott Gottlieb said at a hearing before Congress on a separate matter. “It’s a much broader question about where our responsibility is to step into this.”
This statement hints at two different possibilities:
Further research and full blown clinical trials to prove or disprove cannabis’ potential anti-tumor effects, or
A crackdown on businesses making such claims – possibly like letters sent out previously regarding CBD products, or even more intrusive.
While it is important to make sure that all medical health benefits and claims made should be made with the knowledge that they are correct – or at least proven, to a degree – it is also important to note that many studies prove comparable results, even though they are on a small scale.
Read More Here: